NCT02739919

Brief Summary

The aim of this research is to use a controlled laboratory setting to determine whether bacteria isolated from kidney stones of patients play a role in the formation of non-infectious kidney stones. It is well known that struvite stones are associated with active bacterial infection, however the role of bacteria in the formation of non-infection stones (like calcium oxalate) is not well characterized and there are theories that bacteria are involved in the making of these stones.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 16, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 15, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2016

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 23, 2017

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 24, 2017

Completed
Last Updated

May 2, 2018

Status Verified

November 1, 2016

Enrollment Period

9 months

First QC Date

March 16, 2016

Last Update Submit

April 30, 2018

Conditions

Keywords

Kidney stonesRenal Calculi

Outcome Measures

Primary Outcomes (2)

  • Amount of stone formation in artificial urine with isolated bacteria from non-infection kidney stones compared to control measured using FTIR-Microscopy and SEM (concentration measured in mg/mL).

    Bacteria will be isolated from non-infection kidney stones allowed to form a biofilm. Next, the bacteria will be incubated in supersaturated artificial urine to precipitate stone formation in vitro and compared to control urine consisting of the same artificial urine without bacteria. Over time, crystallization in the biofilm will be measured using FTIR-Microscopy and SEM.

    Through study completion, approximately 2 years

  • Bacteria isolated from non-infection kidney stone compared to those identified on pre-operative urine test quantified by simple serial dilution and CFU counting (measured in CFU/mL) and identified using DNA sequencing.

    Bacteria will be quantified using simple serial dilution and CFU counting and identified using DNA sequencing. Bacteria will then be correlated with the bacteria identified on pre-operative urine test.

    Through study completion, approximately 2 years

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients at Vancouver General Hospital that are diagnosed with a kidney stone and scheduled to undergo percutaneous nephrolithotomy.

You may qualify if:

  • Over the age of 18
  • Diagnosed with or have a high index of suspicion of having a kidney stone and scheduled to undergo percutaneous nephrolithotomy.
  • Medically fit for definitive surgical management of stone

You may not qualify if:

  • Those with medical comorbidities preventing them from safely undergoing definitive surgical therapy.
  • Patients who are unable to provide informed consent.
  • years old or younger
  • Diagnosed with an infection stone
  • Urinary tract infection within 3 months before date of operation
  • Antibiotic use within 3 month before date of operation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Stone Centre, VGH/UBC

Vancouver, British Columbia, V5Z 1M9, Canada

Location

Biospecimen

Retention: SAMPLES WITH DNA

De-identified and study coded kidney stone and urine samples are collected, processed and analysed in the research laboratory.

MeSH Terms

Conditions

UrolithiasisKidney Calculi

Condition Hierarchy (Ancestors)

Urologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesNephrolithiasisKidney DiseasesUrinary CalculiCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Dirk Lange, MSc, PhD

    University of British Columbia

    PRINCIPAL INVESTIGATOR
  • Ben H Chew, MD

    University of British Columbia

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 16, 2016

First Posted

April 15, 2016

Study Start

June 1, 2016

Primary Completion

February 23, 2017

Study Completion

February 24, 2017

Last Updated

May 2, 2018

Record last verified: 2016-11

Data Sharing

IPD Sharing
Will not share

Locations